Search
for
Sort by
Research 181–210 of 1000+
- Cutaneous adverse drug reaction associated with topical use of benzyl benzoate in a dog
- Diet in dermatology: Revisited
- 85 Primary cutaneous follicle center lymphoma spans yet unrecognised subtypes including polyclonal reactions
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- Investigation of the Development of Hypersensitivity and Hyperalgesia After Repeated Application of Platelet-Rich Plasma in Rats: An Experimental Study
- Erythema annulare centrifugum secondary to treatment with finasteride.
- Proposal for Clinical Classification of Cutaneous Manifestations in Covid-19 and in Post Vaccination Against Sars-Cov-2: An Observational Study
- Controversy: Synthetic hairs and their role in hair restoration?
- Dermatotoxicology of microneedles (MNs) in man
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Sensitization and Clinically Relevant Allergy to Hair Dyes and Clothes from Black Henna Tattoos: Do People Know the Risk? An Uncommon Serious Case and a Review of the Literature
- Exploring the Efficacy and Potential Mechanisms of Topical Periplaneta americana (L.) Extract in Treating Androgenetic Alopecia in a Mouse Model: A Systems Pharmacology and Skin Microbiome Analysis
- Permanent Makeup Removal Severe Complication—Case Report and Proposal of the Protocol for Its Management
- Regulatory, Ethical, and Safety Considerations of Exosome‐Based Therapies in Dermatology
- Sildenafil: Looking Beyond Erectile Dysfunction: A Dermatological Perspective
- Madarosis: A marker of many Maladies
- WARFARIN
- TACRINE
- DIETHYLPROPION
- Drug eruptions in dermatology
- Atypical post-finasteride syndrome: A pharmacological riddle
- Side effects after artificial hair implants: 2 case reports
- Topical imiquimod—Be aware of the unexpected
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Adverse cutaneous effects of psychotropic medications
- Severe and Fatal Phenobarbitone Eruptions
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data